Vera Therapeutics, Inc.
VERA
$21.71
-$0.32-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 589.83M | 640.85M | 353.31M | 384.39M | 403.66M |
| Total Receivables | 3.59M | 3.77M | 2.00M | 1.96M | 1.63M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.87M | 5.68M | 7.70M | 7.97M | 10.51M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.79M | 913.00K | 1.13M | 429.00K | 568.00K |
| Total Current Assets | 606.08M | 651.22M | 364.13M | 394.75M | 416.37M |
|
|
|||||
| Total Current Assets | 606.08M | 651.22M | 364.13M | 394.75M | 416.37M |
| Net Property, Plant & Equipment | 3.98M | 4.33M | 4.29M | 2.08M | 2.51M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 114.00K | 131.00K | 140.00K | 460.00K | 473.00K |
| Total Assets | 610.17M | 655.68M | 368.56M | 397.29M | 419.36M |
|
|
|||||
| Total Accounts Payable | 9.26M | 7.67M | 4.60M | 4.66M | 5.21M |
| Total Accrued Expenses | 11.44M | 16.22M | 19.70M | 11.64M | 7.06M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.19M | 1.48M | 1.87M | 2.12M | 2.28M |
| Total Finance Division Other Current Liabilities | -- | -- | 286.00K | -- | -- |
| Total Other Current Liabilities | -- | -- | 286.00K | -- | -- |
| Total Current Liabilities | 21.89M | 25.37M | 26.46M | 18.42M | 14.54M |
|
|
|||||
| Total Current Liabilities | 21.89M | 25.37M | 26.46M | 18.42M | 14.54M |
| Long-Term Debt | 50.91M | 50.69M | 50.47M | 50.26M | 50.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.37M | 2.47M | 2.57M | 455.00K | 919.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 286.00K | 286.00K |
| Total Liabilities | 75.17M | 78.53M | 79.50M | 69.42M | 65.81M |
|
|
|||||
| Common Stock & APIC | 1.05B | 1.04B | 705.84M | 699.51M | 691.20M |
| Retained Earnings | -512.94M | -461.25M | -417.83M | -371.19M | -337.49M |
| Treasury Stock & Other | 654.00K | 393.00K | 1.04M | -450.00K | -173.00K |
| Total Common Equity | 535.00M | 577.16M | 289.06M | 327.87M | 353.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 535.00M | 577.16M | 289.06M | 327.87M | 353.54M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 535.00M | 577.16M | 289.06M | 327.87M | 353.54M |
|
|
|||||